Verheul HMW - Search Results

1

Exploring immune status in peripheral blood and tumor tissue in association with survival in patients with multi-organ metastatic colorectal cancer.

Bakkerus L, Subtil B, Bontkes HJ, Gootjes EC, Reijm M, Vullings M, Verrijp K, Bokhorst JM, Woortman C, Nagtegaal ID, Jonker MA, van der Vliet HJ, Verhoef C, Gorris MAJ, de Vries IJM, de Gruijl TD, Verheul HMW, Buffart TE, Tauriello DVF. Bakkerus L, et al. Among authors: verheul hmw. Oncoimmunology. 2024 Jun 10;13(1):2361971. doi: 10.1080/2162402X.2024.2361971. eCollection 2024. Oncoimmunology. 2024. PMID: 38868078 Free PMC article.

2

Prolonged neoadjuvant treatment in locally advanced tumours: a novel concept based on biological considerations.

Luykx-de Bakker SA, Verheul HM, de Gruijl TD, Pinedo HM. Luykx-de Bakker SA, et al. Ann Oncol. 1999 Feb;10(2):155-60. doi: 10.1023/a:1008360314669. Ann Oncol. 1999. PMID: 10093683 Free article. Review.

3

Angiogenesis inhibitors: perspectives for medical, surgical and radiation oncology.

Verhoef C, de Wilt JH, Verheul HM. Verhoef C, et al. Curr Pharm Des. 2006;12(21):2623-30. doi: 10.2174/138161206777698756. Curr Pharm Des. 2006. PMID: 16842162 Review.

4

Systemic treatment in hepatocellular carcinoma; 'A small step for man...'.

Witjes CD, Verhoef C, Verheul HM, Eskens FA. Witjes CD, et al. Neth J Med. 2009 Mar;67(3):86-90. Neth J Med. 2009. PMID: 19307678 Free article. Review.

5

Case 19-2009: Carcinoma of the gastroesophageal junction.

van der Vliet HJ, van der Peet DL, Verheul HM. van der Vliet HJ, et al. N Engl J Med. 2009 Sep 24;361(13):1315; author reply 1315-6. doi: 10.1056/NEJMc091434. N Engl J Med. 2009. PMID: 19776417 No abstract available.

6

Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin.

Schneiders FL, van den Berg HP, Peters GJ, Verheul HM, van der Vliet HJ. Schneiders FL, et al. Med Oncol. 2011 Dec;28(4):1136-9. doi: 10.1007/s12032-010-9598-9. Epub 2010 Jun 22. Med Oncol. 2011. PMID: 20567941

7

Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

Schneiders FL, Scheper RJ, von Blomberg BM, Woltman AM, Janssen HL, van den Eertwegh AJ, Verheul HM, de Gruijl TD, van der Vliet HJ. Schneiders FL, et al. Clin Immunol. 2011 Aug;140(2):130-41. doi: 10.1016/j.clim.2010.11.010. Epub 2010 Dec 18. Clin Immunol. 2011. PMID: 21169066 Review.

8

Surgery of the primary in stage IV colorectal cancer with unresectable metastases.

Verhoef C, de Wilt JH, Burger JW, Verheul HM, Koopman M. Verhoef C, et al. Eur J Cancer. 2011 Sep;47 Suppl 3:S61-6. doi: 10.1016/S0959-8049(11)70148-4. Eur J Cancer. 2011. PMID: 21944031 Review.

9

Activated iNKT cells promote Vγ9Vδ2-T cell anti-tumor effector functions through the production of TNF-α.

Schneiders FL, de Bruin RC, Santegoets SJ, Bonneville M, Scotet E, Scheper RJ, Verheul HM, de Gruijl TD, van der Vliet HJ. Schneiders FL, et al. Clin Immunol. 2012 Feb;142(2):194-200. doi: 10.1016/j.clim.2011.10.006. Epub 2011 Nov 4. Clin Immunol. 2012. PMID: 22122798

10

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer.

Huijts CM, Santegoets SJ, van den Eertwegh AJ, Pijpers LS, Haanen JB, de Gruijl TD, Verheul HM, van der Vliet HJ. Huijts CM, et al. BMC Cancer. 2011 Nov 30;11:505. doi: 10.1186/1471-2407-11-505. BMC Cancer. 2011. PMID: 22129044 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters